Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients. 1985

H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos

Thirty patients older than 65 years of age with acute nonlymphocytic leukemia were treated with low-dose cytosine arabinoside (10 mg/m2 subcutaneously every 12 hours for 15 to 21 days). Fifteen achieved complete remission and five had partial remission. Treatment was more effective when initial bone marrow cellularity was low (P = 0.007). Four of six patients with secondary leukemia entered complete or partial remission. Therapy was well tolerated with reduced myelosuppression and few number of early deaths. Sixteen patients followed the whole treatment as outpatients. Six of 12 patients who achieved complete remission showed no evidence of post-therapeutic bone marrow aplasia. These data are consistent with the view that low-dose cytosine arabinoside acts on leukemic cells as a differentiating agent.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
January 1988, Acta haematologica,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
March 1989, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
January 1984, American journal of hematology,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
January 1989, Medical and pediatric oncology,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
October 1988, American journal of hematology,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
August 1984, Ugeskrift for laeger,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
January 1992, American journal of hematology,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
October 1994, Ugeskrift for laeger,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
February 1991, International journal of hematology,
H Tilly, and S Castaigne, and D Bordessoule, and F Sigaux, and M T Daniel, and M Monconduit, and L Degos
April 1992, Annals of hematology,
Copied contents to your clipboard!